GlassScriptPhysician profile
Rahul Sharma
NPI 1659754232
$886.15
in general payments reported to CMS, 2019-2025
12 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.62 · 2022: $391 · 2023: $16.89 · 2024: $105 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $386.24 | 2022-2024 | Phasix Mesh |
| Urgo Medical North America, LLC | $194.47 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Abbott Laboratories | $45.15 | 2022 | |
| Prytime Medical Devices, INC. | $42.23 | 2021 | |
| Tela Bio, INC. | $40.91 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $33.75 | 2025 | Echelon; Endopath |
| Polynovo North America LLC | $30.62 | 2024 | Novosorb Btm |
| Intuitive Surgical, INC. | $29.59 | 2025 | |
| Mentor Worldwide LLC | $25.39 | 2021 | |
| Baxter Healthcare | $25.29 | 2025 | Seprafilm |
| Boston Scientific Corporation | $16.89 | 2023 | Spyglass Discover |
| Smith+Nephew, INC. | $15.62 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.